The Bob Harrington Show - Episode 35: Oral antithrombotic agents: An update for the clinical practitioner with Dr Jonathan Halperin

Summary: After decades of reliance on warfarin, there are finally new options for oral anticoagulation, with exciting results from the RE-LY, ROCKET, and AVERROES trials paving the way for dabigatran, rivaroxaban, and apixaban. With over 20 years of experience in the development of antithrombotic therapies, our guest, Dr Jonathan Halperin, discusses the road to approval of these drugs and shares practical insights for the healthcare professionals for finding their way.